Riya Drugs Private Limited, a active private limited company, was established on 29 September 2015 in Surat, Gujarat, India. Engaging in retail trading within the trade sector, it holds CIN: U24232GJ2015PTC084609. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Keyurkumar Manilal Patel (Director), Kirtikumar Manilal Patel (Director), Jayeshkumar Atmarambhai Patel (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 25, Shree Rancchodrai Nagar Ind Estate, Nr. Surat Raktadan, Udhana-Magdalla Road, Surat, Gujarat, 395002.
U24232GJ2015PTC084609
084609
29 September 2015
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Riya Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Keyurkumar Manilal Patel | Director | 29 Sep 2015 | Current |
| Kirtikumar Manilal Patel | Director | 29 Sep 2015 | Current |
| Jayeshkumar Atmarambhai Patel | Director | 29 Sep 2015 | Current |
| Sangita Jayeshkumar Patel | Director | 29 Sep 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Riya Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 65.82% increase. The company also saw a slight improvement in profitability, with a 0.41% increase in profit. The company's net worth moved up by a moderate rise of 7.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Riya Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Riya Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Riya Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riya Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Riya Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Riya Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
The activity Keyurkumar Manilal Patel was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 2 months . was completed.
The activity Kirtikumar Manilal Patel was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 2 months . was completed.
The activity Jayeshkumar Atmarambhai Patel was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 2 months . was completed.
Sangita Jayeshkumar Patel was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.
The CIN of Riya Drugs Private Limited is U24232GJ2015PTC084609.
Riya Drugs Private Limited is headquartered at Plot No. 25, Shree Rancchodrai Nagar Ind Estate, Nr. Surat Raktadan, Udhana-Magdalla Road, Surat, Gujarat, 395002.
Riya Drugs Private Limited was incorporated on 29 September 2015.
The current directors of Riya Drugs Private Limited are
The primary industry of Riya Drugs Private Limited is Trade.
Riya Drugs Private Limited is unlisted.
The authorized capital of Riya Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Riya Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX